Position in DGX
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$2,734,155
+$103,124 QoQ
Shares Held
12,900
-3.9% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#341
of 1,096 holders
Holding Since
Sep 2020
16 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Catalyst Capital Advisors LLC holds $4,258,472 across 4 Diagnostics & Research names. DGX ranks #1 (64.2% of the industry book) .
All Filings in DGX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,734,155 | 12,900 | Shares | Other | 2026-07-24 | |
| 2026-03-31 | $2,631,031 | 13,425 | Shares | Other | 2026-05-06 | |
| 2025-12-31 | $2,433,758 | 14,025 | Shares | Other | 2026-02-10 | |
| 2025-09-30 | $2,777,703 | 14,575 | Shares | Other | 2025-11-12 | |
| 2025-06-30 | $2,734,866 | 15,225 | Shares | Other | 2025-07-31 | |
| 2025-03-31 | $2,694,510 | 15,925 | Shares | Other | 2025-04-29 | |
| 2023-03-31 | $173,313 | 1,225 | Shares | Other | 2023-05-12 | |
| 2022-12-31 | $191,639 | 1,225 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $150,295 | 1,225 | Shares | Other | 2022-11-08 | |
| 2022-06-30 | $162,900 | 1,225 | Shares | Other | 2022-08-09 | |
| 2022-03-31 | $167,653 | 1,225 | Shares | Other | 2022-05-10 | |
| 2021-12-31 | $211,937 | 1,225 | Shares | Other | 2022-02-10 | |
| 2021-09-30 | $178,004 | 1,225 | Shares | Other | 2021-11-09 | |
| 2021-06-30 | $161,663 | 1,225 | Shares | Other | 2021-08-06 | |
| 2021-03-31 | $157,216 | 1,225 | Shares | Other | 2021-05-10 | |
| 2020-09-30 | $188,908 | 1,650 | Shares | Sole | 2020-11-05 | |
| No filing history on record for this holder in this stock. | ||||||